Table 2.
Exposure Duration | Age of Exposure | Species | Chemical | Concentration | Major Endpoints | Reference |
---|---|---|---|---|---|---|
24 h | 56 days old | BALB/c mice |
MeHg | 0–10,000 µg·kg−1 | Accumulation in brain | [49] |
5 days (pre-gestational), 19 days (pregnancy) | Adult | Female Wistar rats | MeHg | 1000 µg·kg−1/day | Neuron loss in the brain, hippocampus and amygdala | [50] |
11 days (2 h/day) |
61–67 days old | Female Sprague-Dawley rats | Hg vapour Hg0 | 1; 2; 4 mg·m−3 | ROS increase in brain and kidney |
[51] |
21 days | 220–250 g | Male albino-Wistar rats | HgCl2 | 400; 800; 1600 µg·kg−1/day | Spatial memory impairments; hippocampal mitochondrial dysfunction | [52] |
28 days | Adult | Male Wistar albino rats | HgCl2 | 1000 µg·kg−1/day | Histopathological changes in the lung tissue; OS | [53] |
28 days | 49 days old | Male Wistar rats | MeHg | 0; 20; 200; 2000 µg·kg−1/day | Accumulation of the Amyloid Beta (Aβ) in the hippocampus | [54] |
28 days | 250–300 g | Male Sprague-Dawley rats | HgCl2 | 1148 µg·kg−1/day | Fibrosis; asthma; OS | [55] |
28 days | 42 days old | Male Sprague-Dawley rats | HgCl2 | 1000 µg·kg−1 | Necrosis; fibrosis in spleen tissue |
[56] |
30 days | Adult 84 days old |
Female Wistar rats | HgCl2 | First dose 4.6 µg·kg−1, subsequent doses 0.07 µg·kg−1/day |
Presence of ovarian cystic follicles; ovarian OS; glucose/insulin intolerance | [57] |
30 days | 56 days old | Male Wistar rats | HgCl2 | First dose 4.6 µg·kg−1, subsequent doses 0.07 µg·kg−1/day |
Anxiety; memory impairment | [58] |
30 days | 56 days old | Male Wistar strain albino rats | HgCl2 | 1250 µg·kg−1 | Apoptosis by caspase−3 |
[59] |
45 days (9 h/day) |
Adult 56–70 days old 150–200 g |
Female Wistar albino rats | Hg vapour | 1 mg·m−3 | Loss of Purkinje cells; deleterious effects on the cerebellum structure | [60] |
45 days | 90 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Cognitive disorders; OS; cytotoxicity; apoptosis induction | [46] |
45 days | 150 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Short and long-term memory impairments; motor deficits; accumulation in hippocampus and cortex | [48] |
45 days | 90 days old | Male Wistar rats | HgCl2 | 375 µg·kg−1/day | Motor disorders; cellular death; apoptosis; OS | [47] |
7, 14, 28, 42, 56 days | 42 days old | Male C57BL/6NJcl mice | MeHg-gluta-thione 1:1 | 30,000 µg·kg−1 | Reduction of antioxidant enzyme expression |
[61] |
56 days | 42 days old | Male C57BL/6NJcl mice | MeHg | 30,000 µg·kg−1 | Neuronal degeneration | [62] |
60 days | 90 days old | Wistar rats | MeHg | 40 µg·kg−1/day | Alveolar bone loss (in height) |
[63] |